申请人:Zhou Jia
公开号:US11117865B2
公开(公告)日:2021-09-14
Certain embodiments are directed to small molecule selective inhibitors of the BRD4 bromodomain. Compounds described herein can be used to modulate the bronchiolar NFkB-BRD4 axis, which plays a role in acute neutrophilic response to viral molecular patterns. Compounds described herein can be developed as preventive and therapeutic agents for various human diseases and conditions.
某些实施方式涉及BRD4溴结构域的小分子选择性抑制剂。本文所述化合物可用于调节支气管NFκB-BRD4轴,其在响应病毒分子模式的急性中性粒细胞反应中发挥重要作用。本文所述化合物可开发为预防和治疗多种人类疾病和状况的药物。